We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
(+20%)
Cap. Flow
+$736M
Cap. Flow
% of AUM
16.32%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$99.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$80.7M |
| 3 |
Johnson & Johnson
JNJ
|
+$77.7M |
| 4 |
Electronic Arts
EA
|
+$61.9M |
| 5 |
Danaher
DHR
|
+$60.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$99.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$97.8M |
| 3 |
Medtronic
MDT
|
+$68.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$61.6M |
| 5 |
Lumentum
LITE
|
+$58.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.83% |
| 2 | Technology | 26.25% |
| 3 | Communication Services | 6.68% |
| 4 | Consumer Discretionary | 4.05% |
| 5 | Financials | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Teradyne
TER
$57.6B
| $41.2M | 0.91% |
+338,928
| New | +$42.6M |
|
27
eBay
EBAY
$50.6B
| $40.9M | 0.91% |
+667,358
| New | +$38.7M |
|
28
Revolution Medicines
RVMD
$39.9B
| $38.6M | 0.86% |
842,062
+34,932
| +4% | +$1.57M |
|
|
AERI
29
DELISTED
Aerie Pharmaceuticals
AERI
| $38.5M | 0.86% |
+2,157,039
| New | +$37.3M |
|
30
Bristol-Myers Squibb
BMY
$133B
| $38.3M | 0.85% |
+606,831
| New | +$37.8M |
|
31
Becton Dickinson
BDX
$45.6B
| $37.2M | 0.83% |
156,856
-3,767
| -2% | -$920K |
|
32
Mercado Libre
MELI
$95.2B
| $35.2M | 0.78% |
23,908
+6,776
| +40% | +$11.5M |
|
33
Teleflex
TFX
$6.05B
| $34.9M | 0.78% |
84,113
+20,878
| +33% | +$8.36M |
|
34
Arcus Biosciences
RCUS
$3.55B
| $34.8M | 0.77% |
+1,237,730
| New | +$43.1M |
|
35
Cirrus Logic
CRUS
$6.53B
| $34.7M | 0.77% |
408,803
+21,559
| +6% | +$1.87M |
|
|
NATI
36
DELISTED
National Instruments Corp
NATI
| $34M | 0.75% |
787,626
+484,952
| +160% | +$21.3M |
|
|
IGMS
37
DELISTED
IGM Biosciences
IGMS
| $33M | 0.73% |
430,683
-109,733
| -20% | -$9.99M |
|
38
KLA
KLAC
$239B
| $32.4M | 0.72% |
980,980
+137,770
| +16% | +$4.15M |
|
39
Intel
INTC
$455B
| $31.9M | 0.71% |
+498,567
| New | +$29.7M |
|
40
Thomson Reuters
TRI
$42.8B
| $31.7M | 0.7% |
+343,700
| New | +$30.6M |
|
41
Pinterest
PINS
$13.4B
| $30.8M | 0.68% |
415,987
-56,118
| -12% | -$4.17M |
|
42
Centene
CNC
$30.7B
| $30.4M | 0.67% |
+475,065
| New | +$29.4M |
|
43
Cooper Companies
COO
$14.1B
| $30.4M | 0.67% |
316,172
-7,828
| -2% | -$743K |
|
|
GLUU
44
DELISTED
Glu Mobile Inc.
GLUU
| $29.6M | 0.66% |
2,375,587
+405,679
| +21% | +$4.52M |
|
45
Viavi Solutions
VIAV
$9.12B
| $28.9M | 0.64% |
1,841,304
-49,136
| -3% | -$793K |
|
46
Waters Corp
WAT
$37B
| $28.8M | 0.64% |
+101,183
| New | +$27.6M |
|
|
ATVI
47
DELISTED
Activision Blizzard
ATVI
| $28.6M | 0.63% |
307,061
-460,968
| -60% | -$43.3M |
|
48
Nutanix
NTNX
$16B
| $28.5M | 0.63% |
1,073,292
+118,586
| +12% | +$3.61M |
|
49
Lyft
LYFT
$6.02B
| $28.1M | 0.62% |
444,680
-173,629
| -28% | -$9.69M |
|
|
KLRS
50
Kalaris Therapeutics
KLRS
$83.5M
| $27.6M | 0.61% |
51,301
+6,089
| +13% | +$5.12M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.
- Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
- Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
- Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
- Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
- Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
- Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
- Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.
Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.